For patients who are naturally B12 deficient, more frequent injections about once a month may be ideal
Side effects and safety profile AOD 9604 is generally well-tolerated
Involvement of ERK1/2 pathway in BPC-157-induced cell proliferation, migration, and tube formation To explore whether the ERK1/2, JNK, or p38 pathway was involved in BPC-157-induced cell proliferation, migration, and tube formation, PD98059 (ERK1/2 inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor) were used
ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article